INTRODUCTION
Pseudomonas aeruginosa,≥ a≥ nonćfermenting≥ Gramćnegative≥ rod≥ of≥ great≥ clinical≥ and≥ epideć miological≥relevance≥in≥hospitalćacquired≥infecć tions,≥is≥more≥frequently≥found≥in≥intensive≥care≥ units≥(ICUs) 1 ≥and≥is≥associated≥with≥high≥morć bimortality. 2 ≥ he≥ selective≥ pressure≥ exerted≥ by≥ the≥ indisć criminate≥use≥of≥antimicrobial≥agents≥in≥the≥last≥ decades≥ might≥ have≥ contributed≥ to≥ the≥ emerć gence≥ of≥ microorganisms≥ that≥ are≥ resistant≥ to≥ diferent≥classes≥of≥antibiotics≥and≥is≥currently≥a≥ matter≥ of≥ worldwide≥ concern. 3 ≥ Several≥ mechać nisms≥are≥involved≥in≥P. aeruginosa≥resistance≥to≥ antimicrobial≥agents,≥such≥as≥chromosomal≥exć pression,≥βćlactamase≥production,≥elux≥pumps≥ and≥decrease≥in≥membrane≥permeability. 4 ≥ he≥currently≥observed≥increased≥resistance≥ to≥carbapenem≥has≥stimulated≥studies≥aiming≥at≥ a≥better≥understanding≥of≥the≥resistance≥mechać nisms≥ of≥ P. aeruginosa. 3, 5, 6 ≥ he≥ emergence≥ and≥ dissemination≥ of≥ metalloćβćlactamases≥ (MBL)≥ have≥ contributed≥ to≥ the≥ high≥ rate≥ of≥ resistance≥ among≥ the≥ P. aeruginosa≥ strains≥ isolated≥ in≥ the≥ last≥decades.≥he≥MBL≥production≥knowledge≥is≥ crucial≥ to≥ implement≥ preventive≥ measures≥ that≥ can≥ curb≥ the≥ expansion≥ of≥ bacteria≥ presenting≥ this≥potent≥resistance≥gene. 3 ≥ he≥ objective≥ of≥ the≥ present≥ study≥ was≥ to≥ investigate≥ metalloćβćlactamase≥ and≥ genetic≥ similarity≥ among≥ P. aeruginosa≥ strains≥ isolated≥ in≥ ICUs≥ of≥ two≥ hospitals≥ in≥ the≥ city≥ of≥ Campo≥ Grande,≥state≥of≥Mato≥Grosso≥do≥Sul,≥Brazil.≥
MATERIALS AND METHODS

Research site and period
he≥ study≥ was≥ carried≥ out≥ with≥ P. aeruginosa≥ strains≥ from≥ patients≥ admitted≥ at≥ adult≥ ICUs,≥ coronary≥ care≥ units≥ (CCUs)≥ and≥ pediatric≥ ≥ ICUs≥(PICUs)≥of≥two≥public≥hospitals≥in≥the≥state≥ of≥Mato≥Grosso≥do≥Sul,≥Brazil,≥from≥01/01/2007≥to≥ 06/31/08.≥Hospital≥A≥is≥a≥250ćbed≥university≥hosć pital≥and≥hospital≥B≥is≥a≥360ćbed≥tertiary≥hospital. P. aeruginosa≥ strains≥ positive≥ for≥ MBL≥ production≥ at≥ the≥ phenotypic≥ test≥ were≥ submitted≥ to≥ conventional≥ PCR.
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≥ he≥ starter≥oligonucleotides≥used≥were:≥blaSPMć1≥F≥(5´CCT≥ACA≥ ATC≥TAA≥CGG≥CGA≥CC3´)≥and≥R≥(5´TCG≥CCG≥TGT≥CCA≥ GGT≥ATA≥AC3´),≥blaIMPć1≥F≥(5´CTA≥CCG≥CAG≥CAG≥AGT≥ CTT≥ TTG3´)≥ and≥ R≥ (5´AAC≥ CAG≥ TTT≥ TGC≥ CTT≥ ACC≥ AT3´)≥ blaIMPć2≥ F≥ (5'GTT≥ TTA≥ TGT≥ GTA≥ TGC≥ TTC≥ CTT≥ TGT≥AGC3')≥and≥R≥(5'CAG≥CCT≥GTT≥CCC≥ATG≥TAC≥G3'),≥ blaVIMć1≥ F≥ (5'GTT≥ TGG≥ TCG≥ CAT≥ ATC≥ GCA≥ AC3')≥ e≥ R≥ (5' AGA≥ CCG≥ CCC≥ GGT≥ AGA≥ CC3'),≥ blaVIMć2≥ F≥ (5´ATG≥ AAA≥GTG≥CGT≥GGA≥GAC3´)≥and≥R≥(5'CTA≥CTC≥AAC≥GAC≥ TGA≥GCG≥ATT≥TGT3'). Polymyxin 00
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Pulsed ield gel electrophoresis
ICUs, intensive care units. 
